/PRNewswire/ On Aug 02, 2022, with the recent surge in raw material prices and the continued scarcity of quercetin in the market, Alps Pharmaceutical Ind..
Sewickley native Miguel Regueiro, M.D., has been named chair of Cleveland Clinic’s Digestive Disease & Surgery Institute. “Dr. Regueiro’s leadership and focus align with our mission of caring for life, researching for health, and educating those who serve,” said Cleveland Clinic’s Chief of Staff Beri Ridgeway, M.D. “His dedication to
Dr. Miguel Regueiro has been named to the position, succeeding Dr. Matthew Walsh, who had served as interim chair since October. Walsh will continue his role as chair of the Department of General Surgery.